Drug Profile
Immunoliposomal 5-fluorodeoxyuridine-dipalmitate
Alternative Names: FUdR-dP immunoliposomal; Immunoliposomal 5-FUdR-dP; Liposomal 5-fluorodeoxyuridine-dipalmitateLatest Information Update: 29 Apr 2002
Price :
$50
*
At a glance
- Originator Nonindustrial source
- Class Monoclonal antibodies
- Mechanism of Action Thymidylate synthase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 30 Aug 1999 Preclinical development for Cancer in Netherlands (Unknown route)